Physician profile
John B Ratcliff
NPI 1063449692
$650.48
in general payments reported to CMS, 2019-2025
13 companies · $88.67 in 2025
The $88.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $44.86 · 2021: $31.64 · 2022: $138 · 2023: $152 · 2024: $56.06 · 2025: $88.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.12 | 2019-2025 | |
| Hologic Sales and Service, LLC | $86.17 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $69.47 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $43.53 | 2019-2020 | |
| Astellas Pharma US INC | $40.18 | 2022-2024 | Veozah |
| Shield Therapeutics INC | $40.04 | 2023-2025 | Accrufer |
| Minerva Surgical, INC | $34.43 | 2022-2023 | |
| Smith+Nephew, INC. | $28.88 | 2022-2024 | Stravix |
| Organon LLC | $24.53 | 2022 | |
| Integra Lifesciences Corporation | $19.62 | 2023 | Biodfactor, Medihoney, Biodrestore |
| Pfizer INC. | $18.11 | 2023 | |
| Kci USA, INC. | $13.90 | 2019 | |
| Avion Pharmaceuticals | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ratcliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.